Depreciation of BriaCell Therapeutics Corp. from 31 Jul 2024 to 31 Oct 2025

Taxonomy & unit: us-gaap: USD
Description: The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary: BriaCell Therapeutics Corp. quarterly and annual Depreciation in USD history and change rate from 31 Jul 2024 to 31 Oct 2025.
BriaCell Therapeutics Corp. Depreciation for the quarter ending 31 Oct 2025 was $22,839, unchanged year-over-year.
BriaCell Therapeutics Corp. annual Depreciation for 2025 was $91,356, a 33% increase from 2024.
Source SEC data: View on sec.gov

Depreciation, Quarterly (USD)

Depreciation, YoY Quarterly Change (%)

Depreciation, Annual (USD)

Depreciation, YoY Annual Change (%)

BriaCell Therapeutics Corp. Quarterly Depreciation (USD)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed	Fiscal Year	Fiscal Period
Q3 2025		$22,839	$0	0%	01 Aug 2025	31 Oct 2025	10-Q	11 Dec 2025	2026	Q1
Q3 2024		$22,839			01 Aug 2024	31 Oct 2024	10-Q	11 Dec 2025	2026	Q1

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed	Fiscal Year	Fiscal Period
2025	$91,356	+$22,730	+33%	01 Aug 2024	31 Jul 2025	10-K	16 Oct 2025	2025	FY
2024	$68,626			01 Aug 2023	31 Jul 2024	10-K	16 Oct 2025	2025	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.